Jintian Pharmaceutical Group Ltd ($2211) - buy or sell? Stock discussion, ideas, forum

Jintian Pharmaceutical Group Ltd

Jintian Pharmaceutical Group Limited retails and distributes pharmaceutical products.

Industry: Retail

Ticker	Exchange	ISIN	Name
$2211	HKEx Main Board	KYG513961022	Code: 2211

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 2211 stock

Share your investment idea or question on Jintian Pharmaceutical Group Ltd stock:

Latest twits on Jintian Pharmaceutical Group Ltd (2211)

No twits yet. Be the first to post!

Have a question about 2211? Ask and other investors will be eager to help you.

Have an idea about 2211? Share it with other investors.

Jintian Pharmaceutical Group Ltd news

24/09/2020 Jintian Pharmaceutical Group Ltd reports 2,951% CAPEX growth in 2020 while 37.7% Revenue decline

23/03/2017 Jintian Pharmaceutical Group Ltd EBITDA dropped on 117% in 2016 and Revenue dropped on 29.7%

31/03/2016 Jintian Pharmaceutical Group Ltd reports 93.4% Net Income decline and 13.4 pp EBITDA Margin decline from 16.4% to 2.9%

25/03/2015 Jintian Pharmaceutical Group Ltd demonstrates fast growth in fundamentals

Jintian Pharmaceutical Group Ltd stock price chart

Jintian Pharmaceutical Group Ltd financials

mln.	FY2010	FY2011	FY2012

Revenue	858.6	1,474	2,326
EBITDA	162.6	249.2	315.6
Net income	122.5	180.1	213.8
CAPEX	1.030	11.742	14.537
Debt	0.000	0.000	42.088
Cash	107.0	713.3	455.9

Jintian Pharmaceutical Group Ltd news

About Jintian Pharmaceutical Group Ltd

Jintian Pharmaceutical Group Limited retails and distributes pharmaceutical products. The Company offers its products through its pharmaceutical retail chain and pharmaceutical distribution centers. Jintian Pharmaceutical Group services the medical industry and customers in Northern China.